Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
免疫检查点 PVR 和 PVRL2 是 AML 的预后标志物,阻断这些标志物代表了一种新的治疗选择
期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-018-0288-y
Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann, Jana Muschhammer, Eik Vettorazzi, Michael Heuser, Ulrike Mock, Felicitas Thol, Gabi Vohwinkel, Emily Latuske, Carsten Bokemeyer, Roman Kischel, Cedric Dos Santos, Sabine Stienen, Matthias Friedrich, Michael Lutteropp, Dirk Nagorsen, Jasmin Wellbroc